{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T14:07:09Z","timestamp":1789222029580,"version":"build-2803163510"},"reference-count":41,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,11]],"date-time":"2026-05-11T00:00:00Z","timestamp":1778457600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clinthera.2026.05.002","type":"journal-article","created":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T19:46:10Z","timestamp":1780170370000},"page":"977-988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Real-World Analysis Comparing Persistence and Adherence of Delayed-Release\/Extended-Release Methylphenidate with Stimulant Medications Among Patients with Attention-Deficit\/Hyperactivity Disorder in the United States"],"prefix":"10.1016","volume":"48","author":[{"given":"Ryan","family":"Gregg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0385-8657","authenticated-orcid":false,"given":"Vamshi Ruthwik","family":"Anupindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordyn","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Weddige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Munnangi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitch","family":"DeKoven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randy","family":"Sallee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2026.05.002_bib0001","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1176\/appi.ajp.2021.21010032","article-title":"Variable patterns of remission from ADHD in the multimodal treatment study of ADHD","volume":"179","author":"Sibley","year":"2022","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0002","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1089\/cap.2014.0160","article-title":"Early morning functioning in stimulant-treated children and adolescents with attention-deficit\/hyperactivity disorder, and its impact on caregivers","volume":"25","author":"Sallee","year":"2015","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0003","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.19m12956","article-title":"Functional impairment in youth with ADHD: normative data and norm-referenced cutoff points for the before school functioning questionnaire and the parent rating of evening and morning behavior scale, revised","volume":"81","author":"Faraone","year":"2019","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0004","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1741-7015-10-99","article-title":"A systematic review and analysis of long-term outcomes in attention deficit hyperactivity disorder: effects of treatment and non-treatment","volume":"10","author":"Shaw","year":"2012","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0005","series-title":"Taking charge of ADHD: the complete, authoritative guide for parents","author":"Barkley","year":"2020"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0006","doi-asserted-by":"crossref","first-page":"e1903","DOI":"10.1002\/mpr.1903","article-title":"Morbidities and mortality of diagnosed attention deficit hyperactivity disorder (ADHD) over the youth lifespan: a population-based retrospective cohort study","volume":"31","author":"Diallo","year":"2022","journal-title":"Int J Methods Psychiatr Res"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0007","series-title":"Database of Abstracts of Reviews of Effects (DARE): Quality-assessed Reviews [Internet]","article-title":"Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis","author":"Faraone","year":"1995"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0008","first-page":"4","article-title":"Comparing the efficacy of medications for ADHD using meta-analysis","volume":"8","author":"Faraone","year":"2006","journal-title":"MedGenMed"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0009","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biopsych.2004.11.043","article-title":"A large, double-blind, randomized clinical trial of methylphenidate in the treatment of adults with attention-deficit\/hyperactivity disorder","volume":"57","author":"Spencer","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0010","first-page":"1543","article-title":"Adherence, persistence, and medication discontinuation in patients with attention-deficit\/hyperactivity disorder - a systematic literature review","volume":"10","author":"Gajria","year":"2014","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0011","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00787-024-02538-z","article-title":"Medication adherence and persistence in children and adolescents with attention deficit hyperactivity disorder (ADHD): a systematic review and qualitative update","volume":"34","author":"Ferrin","year":"2025","journal-title":"Eur Child Adolescent Psychiatry"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2026.05.002_bib0012","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1185\/03007995.2011.603303","article-title":"ADHD medication use, adherence, persistence and cost among Texas Medicaid children","volume":"27","author":"Barner","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0013","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.3111\/13696998.2013.839947","article-title":"Treatment persistence in attention deficit\/hyperactivity disorder: a retrospective analysis of patients initiated on lisdexamfetamine vs other medications","volume":"16","author":"Setyawan","year":"2013","journal-title":"J Med Econ"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0014","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1016\/j.clinthera.2016.07.001","volume":"38","author":"Park-Wyllie","year":"2016","journal-title":"Clin Therap"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0015","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/0269881113519509","article-title":"Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology","volume":"28","author":"Bolea-Alama\u00f1ac","year":"2014","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0016","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1097\/chi.0b013e318054e724","article-title":"Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit\/hyperactivity disorder","volume":"46","author":"Pliszka","year":"2007","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0017","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1087054714548035","article-title":"Drug holidays from ADHD medication: international experience over the past four decades","volume":"19","author":"Ibrahim","year":"2015","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0018","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/JCP.0000000000001222","article-title":"Model-based approach for establishing the predicted clinical response of a delayed-release and extended-release methylphenidate for the treatment of attention-deficit\/hyperactivity disorder","volume":"40","author":"Gomeni","year":"2020","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0019","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1089\/cap.2019.0070","article-title":"A randomized, double-blind, placebo-controlled study of HLD200, a delayed-release and extended-release methylphenidate, in children with attention-deficit\/hyperactivity disorder: an evaluation of safety and efficacy throughout the day and across settings","volume":"30","author":"Childress","year":"2020","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0020","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1089\/cap.2017.0084","article-title":"Efficacy and safety of HLD200, delayed-release and extended-release methylphenidate, in children with attention-deficit\/hyperactivity disorder","volume":"27","author":"Pliszka","year":"2017","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0021","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1176\/appi.ps.201800515","article-title":"Evidence of low adherence to stimulant medication among children and youths with ADHD: an electronic health records study","volume":"70","author":"Biederman","year":"2019","journal-title":"Psychiatr Serv"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0022","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s00213-020-05576-y","article-title":"Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescription","volume":"237","author":"Biederman","year":"2020","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0023","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1177\/10870547251336852","article-title":"Factors associated with medication adherence among patients with attention-deficit\/hyperactivity disorder (ADHD)","volume":"29","author":"Nguyen","year":"2025","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0024","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1548631","article-title":"Adherence and persistence with istradefylline treatment in patients with Parkinson's disease in the United States","volume":"16","author":"Joseph","year":"2025","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0025","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/head.14820","article-title":"Changes in use of acute and preventive medications for migraine after erenumab initiation over 12\u2009months: a United States retrospective cohort study","volume":"65","author":"Multani","year":"2025","journal-title":"Headache"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0026","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1186\/s12888-022-04188-4","article-title":"Treatment patterns among children and adolescents with attention-deficit\/hyperactivity disorder in the United States \u2013 a retrospective claims analysis","volume":"22","author":"Schein","year":"2022","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0027","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S2215-0366(23)00332-2","article-title":"ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases","volume":"11","author":"Brikell","year":"2024","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0028","article-title":"A review of attention-deficit\/hyperactivity disorder in women and girls: uncovering this hidden diagnosis","volume":"16","author":"Quinn","year":"2014","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0029","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1186\/s12888-020-02707-9","article-title":"Females with ADHD: an expert consensus statement taking a lifespan approach providing guidance for the identification and treatment of attention-deficit\/hyperactivity disorder in girls and women","volume":"20","author":"Young","year":"2020","journal-title":"BMC Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0030","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1087054711416909","article-title":"ADHD and female specific concerns: a review of the literature and clinical implications","volume":"16","author":"Nussbaum","year":"2012","journal-title":"J Atten Disord"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0031","first-page":"217","article-title":"Sex and age differences in attention-deficit\/hyperactivity disorder symptoms and diagnoses: implications for DSM-V and ICD-11","volume":"49","author":"Ramtekkar","year":"2010","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0032","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-2528","article-title":"Clinical practice guideline for the diagnosis, evaluation, and treatment of attention-deficit\/hyperactivity disorder in children and adolescents","volume":"144","author":"Wolraich","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0033","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40266-015-0327-0","article-title":"Clinical presentation, diagnosis and treatment of attention-deficit hyperactivity disorder (ADHD) in older adults: a review of the evidence and its implications for clinical care","volume":"33","author":"Goodman","year":"2016","journal-title":"Drugs Aging"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0034","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/jcpp.13480","article-title":"Annual Research Review: attention-deficit\/hyperactivity disorder in girls and women: underrepresentation, longitudinal processes, and key directions","volume":"63","author":"Hinshaw","year":"2022","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0035","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1007\/s00787-009-0054-3","article-title":"Comparing the efficacy of stimulants for ADHD in children and adolescents using meta-analysis","volume":"19","author":"Faraone","year":"2010","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0036","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.neubiorev.2018.02.001","article-title":"The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit\/hyperactivity disorder and other psychiatric comorbidities","volume":"87","author":"Faraone","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0037","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S2215-0366(18)30269-4","article-title":"Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis","volume":"5","author":"Cortese","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0038","article-title":"Amphetamines for attention-deficit hyperactivity disorder (ADHD) in adults","volume":"8","author":"Castells","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0039","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.0181","article-title":"Economic burden associated with extended-release vs immediate-release drug formulations among Medicare Part D and Medicaid beneficiaries","volume":"3","author":"Sumarsono","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.clinthera.2026.05.002_sbref0040","series-title":"Methylphenidate Hydrochloride Extended Release Tablets (generic Concerta) made by Mallinckrodt and Kudco","year":"2016"},{"key":"10.1016\/j.clinthera.2026.05.002_bib0041","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.neubiorev.2021.01.022","article-title":"The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder","volume":"128","author":"Faraone","year":"2021","journal-title":"Neurosci Biobehav Rev"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001487?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291826001487?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T13:31:47Z","timestamp":1789219907000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291826001487"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":41,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S0149291826001487"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.05.002","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-World Analysis Comparing Persistence and Adherence of Delayed-Release\/Extended-Release Methylphenidate with Stimulant Medications Among Patients with Attention-Deficit\/Hyperactivity Disorder in the United States","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2026.05.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Collegium Pharmaceutical. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}